Wesley Peter Blackaby,Martin De Kort,Mark Enthoven,Paul Stuart Hinchliffe,Christian Bernard Matthijs Poulie,Cornelis Marius Timmers,Saskia Verkaik
申请号：
US14812739
公开号：
US10155259B2
申请日:
2015.07.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to FSH receptor antagonist according to general formula Ior a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.
